Cited by 26Transcranial Magnetic Stimulation StudiesTreatment of Major DepressionElectroconvulsive Therapy Studies

Is accelerated, high-dose theta burst stimulation a panacea for treatment-resistant depression?

Open access
Caulfield, Kevin A.·2020·Journal of Neurophysiology

Abstract

A recent study by Williams et al. (Williams NR, Sudheimer KD, Bentzley BS, Pannu J, Stimpson KH, Duvio D, Cherian K, Hawkins J, Scherrer KH, Vyssoki B, DeSouza D, Raj KS, Keller J, Schatzberg AF. Brain 141: e18, 2018) used accelerated, high-dose intermittent theta burst stimulation (iTBS) to treat highly treatment-resistant depression patients. Remarkably, most patients remitted, but the durability of therapeutic response was weak and all patients relapsed within 2 wk posttreatment. This mini-review examines the “fast on, fast off” effects of accelerated, high-dose iTBS for depression and suggests a new treatment that would combine the strengths of multiple extant iTBS protocols.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/jn.00537.2019

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The SAINT/SNT TMS paradigm shows rapid and significant antidepressant effects with remission rates up to 78.6% in randomized controlled trials.

    “Notably, the SAINT/SNT paradigm, shows rapid and significant effects with remission rates up to 78.6% in randomized controlled trials [108,109,110,111].”

    From The Heart’s Electromagnetic Field in Emotions, Empathy and Human Connection: Biosensor-Derived Insights into Heart–Brain Axis Mechanisms and a Basis for Novel BioMagnetoTherapies (2026) · cites this paper as [109]

    In “A Second Benefit of TBS: Accelerated, High-Dose Treatment Protocols” (page not specified), the paper reports rapid remission with accelerated iTBS in five of six patients. It gives a remission rate of 83.3%, not 78.6%, and does not identify that six-patient study as a randomized controlled trial or call its protocol SAINT/SNT. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Single-pulse TMS reduces monthly headache days in migraines, especially with aura, sustained up to 12 months in difficult-to-treat cohorts, but results for chronic migraine remain inconclusive.

    “In migraines, especially with aura, single-pulse TMS studies report significant reductions in monthly headache days, sustained up to 12 months in difficult-to-treat cohorts [107,108,109,110,111,119,120,121,122], while results for chronic migraine remain inconclusive [117,122].”

    From The Heart’s Electromagnetic Field in Emotions, Empathy and Human Connection: Biosensor-Derived Insights into Heart–Brain Axis Mechanisms and a Basis for Novel BioMagnetoTherapies (2026) · cites this paper as [109]

    The section “A Brief Background on Transcranial Magnetic Stimulation” says that an FDA-approved treatment for migraine with aura uses a single TMS pulse. It does not report reductions in monthly headache days, effects sustained for 12 months in difficult-to-treat cohorts, or inconclusive results for chronic migraine. Page numbers are not available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Caulfield, K. A.
Affiliations
Medical University of South Carolina (US)
Corresponding author
Caulfield, Kevin A.
Venue
Journal of Neurophysiology
Published
2020-01-01
Volume
123
Issue
1
Pages
1-3
ISSN
  • 0022-3077 (ISSN-L)
  • 1522-1598
OpenAlex
W2975161579
Cited by
26
References
14
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 4
FWCI
1.65
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurophysiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
intermittent theta burst stimulation, treatment-resistant depression, remission, relapse, non-invasive brain stimulation
MeSH terms
Humans, Outcome Assessment, Health Care, Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review